Except for oral semaglutide, theyre typically subcutaneous injections (administered into the fatty tissue just under the skin)
Yes, drugs like Wegovy are FDA-approved for obesity management in non-diabetic patients
Is there a placebo arm, and what is the randomization ratio
To determine if this is the most appropriate treatment, pharmacists should consider the following: Administration burden: Include frequency of use and timing with meals
Liraglutide (Victoza) | FDA Approved 2010 In 2010, liraglutide strolled onto the scene
In the phase 2b trial, however, the reductions in glycated hemoglobin and body weight in participants treated with NNC0090-2746 were similar to those in the group treated with liraglutide (76), and no phase 3 trial of NNC0090-2746 has been reported yet